Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR) crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$13.36 and traded as low as C$10.62. Cipher Pharmaceuticals shares last traded at C$10.92, with a volume of 43,185 shares changing hands.
Analyst Ratings Changes
Separately, Stifel Nicolaus dropped their price target on Cipher Pharmaceuticals from C$19.00 to C$17.00 in a research report on Monday, November 11th.
Get Our Latest Analysis on CPH
Cipher Pharmaceuticals Stock Down 3.3 %
About Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.
Recommended Stories
- Five stocks we like better than Cipher Pharmaceuticals
- Stock Market Upgrades: What Are They?
- How to Protect Your Portfolio When Inflation Is Rising
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Pros And Cons Of Monthly Dividend Stocks
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.